Sailaja Paruchuri Selected Research

Sailaja Paruchuri Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 04/2005
5	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2015
5	Asthma (Bronchial Asthma) 01/2021 - 10/2009
4	Inflammation (Inflammations) 01/2021 - 11/2013
3	Respiratory Hypersensitivity 01/2013 - 06/2008
2	Atherosclerosis 01/2021 - 11/2013
2	Pneumonia (Pneumonitis) 03/2015 - 10/2009
2	type 2C Congenital disorder of glycosylation 10/2009 - 06/2008
2	Eosinophilia 10/2009 - 06/2008
1	Pathologic Neovascularization 01/2021
1	Airway Remodeling 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Edema (Dropsy) 01/2016
1	Otitis 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Lung Neoplasms (Lung Cancer) 07/2015
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Triple Negative Breast Neoplasms 07/2015
1	Hyperplasia 03/2015
1	Myocardial Infarction 11/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2013
1	Hypersensitivity (Allergy) 01/2013
1	Metaplasia 10/2009
1	Sarcoma (Soft Tissue Sarcoma) 06/2008
1	Hemangioma (Angioma) 08/2006
1	Colonic Neoplasms (Colon Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

5	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2021 - 10/2009
4	Leukotriene D4IBA 01/2021 - 04/2005
3	rho-Associated KinasesIBA 01/2021 - 11/2013
3	Ion Channels (Ion Channel)IBA 01/2019 - 05/2016
3	LeukotrienesIBA 01/2016 - 10/2009
2	Dextrans (Dextran)FDA Link 01/2021 - 01/2019
2	Conditioned Culture MediaIBA 01/2021 - 01/2019
2	cadherin 5IBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2019
2	cysteinyl-leukotrieneIBA 01/2019 - 01/2013
2	SaltsIBA 01/2017 - 07/2015
2	CalciumIBA 01/2016 - 06/2008
2	Leukotriene E4IBA 01/2016 - 10/2009
2	Prostaglandin D2IBA 01/2016 - 10/2009
2	ProstaglandinsIBA 01/2016 - 06/2008
2	ChemokinesIBA 10/2009 - 06/2008
1	oxidized low density lipoproteinIBA 01/2021
1	matrigelIBA 01/2021
1	GelatinasesIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	NADPH Oxidase 4IBA 01/2020
1	TRPV Cation ChannelsIBA 01/2019
1	Texas redIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 05/2016
1	Y 27632IBA 05/2016
1	Dinoprostone (PGE2)FDA Link 01/2016
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2016
1	Fura-2 (Fura 2)IBA 01/2016
1	Arachidonic Acid (Vitamin F)IBA 01/2016
1	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 01/2016
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 09/2015
1	NitrogenIBA 07/2015
1	CationsIBA 07/2015
1	naphthaleneIBA 07/2015
1	PhytochemicalsIBA 07/2015
1	Stem Cell FactorIBA 03/2015
1	Bronchoconstrictor AgentsIBA 01/2013
1	LipidsIBA 01/2013
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2013
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2009
1	Interleukin-13IBA 10/2009
1	Adenosine Diphosphate (ADP)IBA 10/2009
1	AllergensIBA 10/2009
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2008
1	Prostaglandins DIBA 06/2008
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2008
1	Angiogenesis InhibitorsIBA 08/2006
1	EndostatinsIBA 08/2006
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2003
1	Leukotriene Receptors (Leukotriene Receptor)IBA 01/2003

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2016
1	Drug Therapy (Chemotherapy) 07/2015